Skip to main content
TipRanks
Go Ultimate75% OFF

Amoeba SA (ALMIB) Stock Price & Analysis

4 Followers

ALMIB Stock Chart & Stats

€0.31€0.02(8.01%)
At close: 5:30 PM GMT+1
€0.25€0.5Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 0.28 - EUR 0.32
52-Week Range
EUR 0.25 - EUR 1.12
Previous Close
EUR 0.29
Volume
N/A
Average Volume (3M)
593.92K
Market Cap
EUR 40.10M
Enterprise Value
EUR 78.49M
Total Cash (Recent Filing)
EUR 5.52M
Total Debt (Recent Filing)
EUR 12.67M
Price to Earnings (P/E)
―
Beta
1.24
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Biotechnology Platform

A proprietary biological platform gives Amoéba a defined foundation for developing multiple products across crop protection and industrial applications. If regulatory and commercial execution progress, the same underlying technology could support broader product expansion over the next several quarters.

Diversified Application Potential

Amoéba is pursuing more than one end market, spanning sustainable agriculture and industrial bio-based applications. This broadens the potential commercial opportunity for its technology and may reduce dependence on a single product category if launches and approvals advance.

Reduced Losses And Cash Burn

Although performance remains weak, the narrowing of operating losses and improvement in free cash flow indicate some movement toward better financial control. Sustaining this direction could extend the company’s funding runway and improve the feasibility of scaling its platform.

Bears Say

Revenue Collapse

Revenue falling to zero shows that the business has not yet established dependable commercial traction. Without recurring sales, Amoéba cannot demonstrate durable market adoption or generate an internal funding source for continued research, regulatory work, and commercialization.

Negative Equity And Rising Debt

Negative equity combined with materially higher debt weakens financial flexibility and increases dependence on refinancing or additional capital. This structure can constrain investment in the platform and leaves the company less able to absorb delays in commercialization or regulatory progress.

Persistent Cash Burn

Consistently negative operating and free cash flow means current activities are not self-funding. Continued cash consumption may require external financing to maintain operations and investment, creating dilution or refinancing pressure while revenue remains unproven.

Amoeba SA News

ALMIB FAQ

What was Amoeba SA’s price range in the past 12 months?
Amoeba SA lowest stock price was €0.25 and its highest was €1.12 in the past 12 months.
What is Amoeba SA’s market cap?
Amoeba SA’s market cap is €40.10M.
When is Amoeba SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Amoeba SA’s earnings last quarter?
Amoeba SA released its earnings results on Sep 24, 2026. The company reported -€0.095 earnings per share for the quarter.
Is Amoeba SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Amoeba SA pay dividends?
Amoeba SA does not currently pay dividends.
What is Amoeba SA’s EPS estimate?
Amoeba SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amoeba SA have?
Amoeba SA has 129,179,120 shares outstanding.
What happened to Amoeba SA’s price movement after its last earnings report?
Amoeba SA reported an EPS of -€0.095 in its last earnings report. Following the earnings report the stock price went down -3.421%.
Which hedge fund is a major shareholder of Amoeba SA?
Currently, no hedge funds are holding shares in FR:ALMIB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology